Nanolive is a Swiss-based startup that operates in the biotechnology sector, specifically in the field of cell biology. The company has developed a unique approach to live cell imaging and analysis, using a technology called holotomography. This technology allows scientists to observe and analyze cells in their natural, living state without the need for labels or dyes, which can potentially alter the cells' behavior.

Nanolive's primary product is the 3D Cell Explorer 96focus, an automated, AI-powered imaging and analysis solution. This tool enables researchers to capture and analyze high-quality, 3D images of live cells. The company's technology is particularly beneficial for fundamental research and drug development, as it allows for long-term monitoring of cells and provides high content, multiplexed, reliable live cell data.

The company's business model is based on selling their imaging and analysis platforms to research institutions and pharmaceutical companies. They also offer digital assays, which are tests that measure the presence, amount, or functional activity of a target entity. These assays can be used to profile cell health and death, measure lipid droplet characteristics, and observe how live T cells interact with their targets.

In terms of financials, Nanolive generates revenue through the sale of their imaging and analysis platforms and digital assays. The company's unique technology and the growing demand for advanced cell imaging solutions position it well for future growth.

Keywords: Biotechnology, Cell Biology, Live Cell Imaging, Holotomography, 3D Cell Explorer 96focus, AI-Powered Analysis, Drug Development, Digital Assays, Research Institutions, Pharmaceutical Companies.